Clinical Trial Update: Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses [Phase 1]

View source ↗

Summary

Phase I study in healthy volunteers to assess safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4017 after repeated ascending oral doses; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD4017

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED